{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:35:27Z","timestamp":1761708927777,"version":"3.40.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,11]],"date-time":"2013-11-11T00:00:00Z","timestamp":1384128000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2377-13-170","type":"journal-article","created":{"date-parts":[[2013,11,11]],"date-time":"2013-11-11T08:01:28Z","timestamp":1384156888000},"source":"Crossref","is-referenced-by-count":17,"title":["Cerebral hemodynamics and endothelial function in patients with Fabry disease"],"prefix":"10.1186","volume":"13","author":[{"given":"Tom\u00e1s","family":"Segura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Ayo-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"G\u00f3mez-Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A","family":"Barba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Vivancos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,11]]},"reference":[{"key":"888_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1471-2377-11-61","volume":"11","author":"AP Burlina","year":"2011","unstructured":"Burlina AP, Sims KB, Politei JM, Bennett GJ, Baron R, Sommer C, et al: Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel. BMC Neurol. 2011, 11: 61-10.1186\/1471-2377-11-61.","journal-title":"BMC Neurol"},{"key":"888_CR2","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.clinbiochem.2011.04.022","volume":"44","author":"B Celtikci","year":"2011","unstructured":"Celtikci B, Top\u00e7u M, Ozkara HA: Two novel alpha-galactosidase a mutations causing fabry disease: a missense mutation M11V in a heterozygote woman and a nonsense mutation R190X in a hemizygote man. Clin Biochem. 2011, 44: 809-812. 10.1016\/j.clinbiochem.2011.04.022.","journal-title":"Clin Biochem"},{"key":"888_CR3","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1399-0004.2011.01718.x","volume":"81","author":"O Lidove","year":"2012","unstructured":"Lidove O, Kaminsky P, Hachulla E, Leguy-Seguin V, Lavigne C, Marie I, et al: Fabry disease 'The New great Imposter\u2019: results of the French observatoire in internal medicine departments (FIMeD). Clin Genet. 2012, 81: 571-577. 10.1111\/j.1399-0004.2011.01718.x.","journal-title":"Clin Genet"},{"key":"888_CR4","first-page":"191","volume":"13","author":"G Altarescu","year":"2011","unstructured":"Altarescu G, Elstein D: Fabry disease in an oligosymptomatic male. Isr Med Assoc J. 2011, 13: 191-192.","journal-title":"Isr Med Assoc J"},{"key":"888_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2147\/DDDT.S11985","volume":"5","author":"U Ramaswami","year":"2011","unstructured":"Ramaswami U: Update on role of agalsidase alfa in management of Fabry disease. Drug Des Devel Ther. 2011, 5: 155-173.","journal-title":"Drug Des Devel Ther"},{"key":"888_CR6","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1161\/STROKEAHA.110.579409","volume":"41","author":"R Brouns","year":"2010","unstructured":"Brouns R, Thijs V, Eyskens F, Van den Broeck M, Belachew S, Van Broeckhoven C, et al: Belgian Fabry study: prevalence of Fabry disease in a cohort of 1000 young patients with cerebrovascular disease. Stroke. 2010, 41: 863-868. 10.1161\/STROKEAHA.110.579409.","journal-title":"Stroke"},{"key":"888_CR7","first-page":"69","volume":"7","author":"M Alfadhel","year":"2011","unstructured":"Alfadhel M, Sirrs S: Enzyme replacement therapy for Fabry disease: some answers but more questions. Ther Clin Risk Manag. 2011, 7: 69-82.","journal-title":"Ther Clin Risk Manag"},{"key":"888_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10072-009-0211-y","volume":"31","author":"A Salviati","year":"2010","unstructured":"Salviati A, Burlina AP, Borsini W: Nervous system and Fabry disease, from symptoms to diagnosis: damage evaluation and follow-up in adult patients, enzyme replacement, and support therapy. Neurol Sci. 2010, 31: 299-306. 10.1007\/s10072-009-0211-y.","journal-title":"Neurol Sci"},{"key":"888_CR9","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s10545-011-9308-6","volume":"34","author":"JM Aerts","year":"2011","unstructured":"Aerts JM, Kallemeijn WW, Wegdam W, Joao Ferraz M, van Breemen MJ, Dekker N, et al: Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies. J Inherit Metab Dis. 2011, 34: 605-619. 10.1007\/s10545-011-9308-6.","journal-title":"J Inherit Metab Dis"},{"key":"888_CR10","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/S0140-6736(05)67635-0","volume":"366","author":"A Rolfs","year":"2005","unstructured":"Rolfs A, B\u00f6ttcher T, Zschiesche M, Morris P, Winchester B, Bauer P, et al: Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet. 2005, 366: 1794-1796. 10.1016\/S0140-6736(05)67635-0.","journal-title":"Lancet"},{"key":"888_CR11","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/jmg.38.11.769","volume":"38","author":"KD MacDermot","year":"2001","unstructured":"MacDermot KD, Holmes A, Miners AH: Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet. 2001, 38: 769-775. 10.1136\/jmg.38.11.769.","journal-title":"J Med Genet"},{"issue":"Suppl 2","key":"888_CR12","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1097\/01.ASN.0000015239.57436.18","volume":"13","author":"EH Kolodny","year":"2002","unstructured":"Kolodny EH, Pastores GM: Anderson-Fabry disease: extrarenal, neurologic manifestations. J Am Soc Nephrol. 2002, 13 (Suppl 2): S150-S153.","journal-title":"J Am Soc Nephrol"},{"key":"888_CR13","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s00415-004-0364-9","volume":"251","author":"MJ Hilz","year":"2004","unstructured":"Hilz MJ, Kolodny EH, Brys M, Stemper B, Haendl T, Marthol H: Reduced cerebral blood flow velocity and impaired cerebral autoregulation in patients with Fabry disease. J Neurol. 2004, 251: 564-570. 10.1007\/s00415-004-0364-9.","journal-title":"J Neurol"},{"key":"888_CR14","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1161\/hc3801.096352","volume":"104","author":"DF Moore","year":"2001","unstructured":"Moore DF, Scott LT, Gladwin MT, Altarescu G, Kaneski C, Suzuki K, et al: Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy. Circulation. 2001, 104: 1506-1512. 10.1161\/hc3801.096352.","journal-title":"Circulation"},{"key":"888_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1159\/000337906","volume":"67","author":"E Azevedo","year":"2012","unstructured":"Azevedo E, Mendes A, Seixas D, Santos R, Castro P, Ayres-Basto M, Rosengarten B, Oliveira JP: Functional transcranial Doppler: presymptomatic changes in Fabry disease. Eur Neurol. 2012, 67: 331-337. 10.1159\/000337906.","journal-title":"Eur Neurol"},{"key":"888_CR16","doi-asserted-by":"crossref","first-page":"598","DOI":"10.33588\/rn.4310.2005544","volume":"43","author":"PE Jim\u00e9nez-Caballero","year":"2006","unstructured":"Jim\u00e9nez-Caballero PE, Segura T: Normal values of cerebral vasomotor reactivity using the breath-holding test. Rev Neurol. 2006, 43: 598-602.","journal-title":"Rev Neurol"},{"key":"888_CR17","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1159\/000343145","volume":"34","author":"PJ Touboul","year":"2012","unstructured":"Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Hernandez Hernandez R, Jaff M, Kownator S, Naqvi T, Prati P, Rundek T, Sitzer M, Schminke U, Tardif JC, Taylor A, Vicaut E, Woo KS: Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). an update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European stroke conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis. 2012, 34: 290-296. 10.1159\/000343145.","journal-title":"Cerebrovasc Dis"},{"key":"888_CR18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","volume":"39","author":"MC Corretti","year":"2002","unstructured":"Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al: Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force. J Am Coll Cardiol. 2002, 39: 257-265.","journal-title":"J Am Coll Cardiol"},{"key":"888_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ymgme.2009.10.004","volume":"99","author":"SM Rombach","year":"2010","unstructured":"Rombach SM, Twickler TB, Aerts JM, Linthorst GE, Wijburg FA, Hollak CE: Vasculopathy in patients with Fabry disease: current controversies and research directions. Mol Genet Metab. 2010, 99: 99-108. 10.1016\/j.ymgme.2009.10.004.","journal-title":"Mol Genet Metab"},{"key":"888_CR20","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1046\/j.1471-4159.2001.00669.x","volume":"79","author":"Y Itoh","year":"2001","unstructured":"Itoh Y, Esaki T, Cook M, Qasba P, Shimoji K, Alroy J, et al: Local and global cerebral blood flow and glucose utilization in the alpha-galactosidase a knockout mouse model of fabry disease. J Neurochem. 2001, 79: 1217-1224.","journal-title":"J Neurochem"},{"key":"888_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/01.nrl.0000187495.16824.a6","volume":"12","author":"JM Politei","year":"2006","unstructured":"Politei JM, Capizzano AA: Magnetic resonance image findings in 5 young patients with Fabry disease. Neurologist. 2006, 12: 103-105. 10.1097\/01.nrl.0000187495.16824.a6.","journal-title":"Neurologist"},{"key":"888_CR22","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1161\/01.STR.32.7.1559","volume":"32","author":"G Altarescu","year":"2001","unstructured":"Altarescu G, Moore DF, Pursley R, Campia U, Goldstein S, Bryant M, et al: Enhanced endothelium-dependent vasodilation in Fabry disease. Stroke. 2001, 32: 1559-1562. 10.1161\/01.STR.32.7.1559.","journal-title":"Stroke"},{"key":"888_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/1531-8249(200002)47:2<229::AID-ANA13>3.0.CO;2-T","volume":"47","author":"T DeGraba","year":"2000","unstructured":"DeGraba T, Azhar S, Dignat-George F, Brown E, Bouti\u00e8re B, Altarescu G, et al: Profile of endothelial and leukocyte activation in Fabry patients. Ann Neurol. 2000, 47: 229-233. 10.1002\/1531-8249(200002)47:2<229::AID-ANA13>3.0.CO;2-T.","journal-title":"Ann Neurol"},{"key":"888_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1651-2227.2002.tb03112.x","volume":"91","author":"K Demuth","year":"2002","unstructured":"Demuth K, Germain DP: Endothelial markers and homocysteine in patients with classic Fabry disease. Acta Paediatr Suppl. 2002, 91: 57-61.","journal-title":"Acta Paediatr Suppl"},{"key":"888_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ymgme.2008.06.016","volume":"95","author":"JS Shen","year":"2008","unstructured":"Shen JS, Meng XL, Moore DF, Quirk JM, Shayman JA, Schiffmann R, et al: Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells. Mol Genet Metab. 2008, 95: 163-168. 10.1016\/j.ymgme.2008.06.016.","journal-title":"Mol Genet Metab"},{"key":"888_CR26","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.1161\/ATVBAHA.107.143511","volume":"27","author":"MP Gelderman","year":"2007","unstructured":"Gelderman MP, Schiffmann R, Simak J: Elevated endothelial microparticles in Fabry children decreased after enzyme replacement therapy. Arterioscler Thromb Vasc Biol. 2007, 27: e138-e139. 10.1161\/ATVBAHA.107.143511.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"888_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0092-8674(90)90230-C","volume":"62","author":"L Osborn","year":"1990","unstructured":"Osborn L: Leukocyte adhesion to endothelium in inflammation. Cell. 1990, 62: 3-6. 10.1016\/0092-8674(90)90230-C.","journal-title":"Cell"},{"key":"888_CR28","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/1529-0131(200005)43:5<1122::AID-ANR23>3.0.CO;2-7","volume":"43","author":"M Tokuhira","year":"2000","unstructured":"Tokuhira M, Hosaka S, Volin MV, Haines GK, Katschke KJ, Kim S, et al: Soluble vascular cell adhesion molecule 1 mediation of monocyte chemotaxis in rheumatoid arthritis. Arthritis & Rheumatism. 2000, 43: 1122-1133. 10.1002\/1529-0131(200005)43:5<1122::AID-ANR23>3.0.CO;2-7.","journal-title":"Arthritis & Rheumatism"},{"key":"888_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cca.2005.12.030","volume":"368","author":"J Constans","year":"2006","unstructured":"Constans J, Conri C: Circulating markers of endothelial function in cardiovascular disease. Clin Chim Acta. 2006, 368: 33-47. 10.1016\/j.cca.2005.12.030.","journal-title":"Clin Chim Acta"},{"key":"888_CR30","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1093\/ndt\/gfp263","volume":"24","author":"AC Vedder","year":"2009","unstructured":"Vedder AC, Bir\u00f3 E, Aerts JM, Nieuwland R, Sturk G, Hollak CE: Plasma markers of coagulation and endothelial activation in Fabry disease: impact of renal impairment. Nephrol Dial Transplant. 2009, 24: 3074-3081. 10.1093\/ndt\/gfp263.","journal-title":"Nephrol Dial Transplant"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-13-170.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2377-13-170\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-13-170","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T20:08:07Z","timestamp":1746043687000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/1471-2377-13-170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,11]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["888"],"URL":"https:\/\/doi.org\/10.1186\/1471-2377-13-170","relation":{},"ISSN":["1471-2377"],"issn-type":[{"type":"electronic","value":"1471-2377"}],"subject":[],"published":{"date-parts":[[2013,11,11]]},"article-number":"170"}}